Alector (ALEC) Free Cash Flow Growth (3y) (2021 - 2026)
Alector (ALEC) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Alector | 167.54 Mn | -38.97 Mn | - | -0.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.67% |
| Dec 31, 2025 | 3.24% |
| Sep 30, 2025 | 13.92% |
| Jun 30, 2025 | 5.55% |
| Mar 31, 2025 | -34.85% |
| Dec 31, 2024 | -4.19% |
| Sep 30, 2024 | -28.30% |
| Jun 30, 2024 | -12.57% |
| Mar 31, 2024 | -5.09% |
| Dec 31, 2023 | -1.84% |
| Sep 30, 2023 | -5.17% |
| Jun 30, 2023 | 2.05% |
| Mar 31, 2023 | -10.84% |
| Dec 31, 2022 | -16.91% |
| Sep 30, 2022 | -14.11% |
| Jun 30, 2022 | -66.46% |
| Mar 31, 2022 | 83.90% |
| Dec 31, 2021 | -26.27% |
| Sep 30, 2021 | 178.35% |
| Jun 30, 2021 | -39.11% |